首页 | 本学科首页   官方微博 | 高级检索  
检索        

螺旋断层放疗鼻咽癌2年经验总结
引用本文:杜镭,马林,冯林春,周桂霞,曲宝林,任刚,徐寿平,谢传滨,张欣欣,李方.螺旋断层放疗鼻咽癌2年经验总结[J].军医进修学院学报,2011,32(1):48-51.
作者姓名:杜镭  马林  冯林春  周桂霞  曲宝林  任刚  徐寿平  谢传滨  张欣欣  李方
作者单位:1. 解放军总医院放疗科,北京,100853
2. 解放军总医院耳鼻咽喉头颈外科,北京,100853
3. 解放军总医院肿瘤内科,北京,100853
摘    要:目的总结解放军总医院螺旋断层放疗鼻咽癌的2年临床经验及近期结果。方法 2007年9月-2009年9月间收治73例初治鼻咽癌患者,其中单纯放疗24例,同步综合治疗49例。处方剂量:原发灶及转移淋巴结计划靶区70-74Gy/33F,高危计划靶区60-62.7Gy/33F,低危计划靶区52-56Gy/33F。根据RTOG/EORTC标准评价急性反应。结果平均出束治疗时间为468.8s。放疗急性反应发生率:皮肤0级2.7%,1级76.7%,2级13.8%,3级6.8%;口腔黏膜0级1.4%,1级32.9%,2级60.2%,3级5.5%;口干0级4.0%,1级45.3%,2级50.7%。口干症随时间逐渐缓解,至放疗结束后1年无≥2级口干。同步化疗显著增加了急性反应。放疗结束1月时,鼻咽原发病灶及颈部转移性淋巴结消退率分别为91.8%和98.1%。中位随访时间14.8个月。2例患者放疗结束后肿瘤局部复发,2例患者出现远处转移。1年无复发生存率、无远处转移生存率及总生存率分别为95.6%、97.2%和94.8%。结论鼻咽癌螺旋断层放疗是一种高效、安全、有效的治疗方式。

关 键 词:鼻咽癌  断层调强放疗  急性反应  生存率

Two-year experiences in treatment of nasopharyngeal carcinoma with helical tomotherapy
DU Lei,MA Lin,FENG Lin-chun,ZHOU Gui-xia,QU Bao-lin,REN Gang,XU Shou-ping,XIE Chuan-bin,ZHANG Xin-xin,LI Fang.Two-year experiences in treatment of nasopharyngeal carcinoma with helical tomotherapy[J].Academic Journal of Pla Postgraduate Medical School,2011,32(1):48-51.
Authors:DU Lei  MA Lin  FENG Lin-chun  ZHOU Gui-xia  QU Bao-lin  REN Gang  XU Shou-ping  XIE Chuan-bin  ZHANG Xin-xin  LI Fang
Institution:DU Lei1,MA Lin1,FENG Lin-chun1,ZHOU Gui-xia1,QU Bao-lin1,REN Gang1,XU Shou-ping1,XIE Chuan-bin1,ZHANG Xin-xin2,LI Fang3 1Department of Radiation Oncology,2Department of Otolaryngology,3Department of Medical Oncology Chinese PLA General Hospital,Beijing 100853,China
Abstract:Objective To summarize the experience in treatment of nasopharyngeal carcinoma(NPC) with helical tomotherapy in our hospital.Methods Of the 73 NPC patients admitted to our hospital from September 2007 and September 2009,24 were treated with simple tomotherapy,49 were treated with combined tomotherapy and medical therapy.The tomotherapy dose was 70–74Gy/33F for primary tumor and metastatic lymph node target region,60–62.7Gy/33F for high risk target region,and 52–56Gy/33F for low risk target region,respectively.Acute side-effects were evaluated following the established RTOG/EORTC criteria.Results The average beam-on time was 468.8s.The incidence rate of skin toxicity was 2.7%,76.7%,13.8% and 6.8%,respectively for grades 0-3.The incidence rate of oral mucositis was 1.4%,32.9%,60.2% and 5.5%,respectively for grades 0-3.The incidence rate of xerostomia was 4.0%,45.3% and 50.7%,respectively for grades 0-2.Xerostomia relived gradually with time and no grade 2 or higher xerostomia was noted one year after tomotherapy.Combined tomotherapy and chemotherapy significantly increased the incidence of severe acute side effects.One month after tomotherapy,the remission rate of NPC and lymph node metastasis was 91.8% and 98.1%,respectively.The median follow-up was 14.8 months.Two patients had a local recurrence and 2 patients developed distant metastasis.The relapse-free survival,distant metastasis-free survival and one-year overall survival rates were 95.6% 97.2% and 94.8%,respectively.Conclusion As a curative treatment modality,helical tomotherapy is effective and safe for NPC.
Keywords:Nasopharyngeal Cancer  Helical Tomotherapy  Acute Toxicities  Survival  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号